Biopharm Business - BioPharm International


Biopharm Business
Insight and analysis to business aspects of biopharmaceutical development. Mergers, acquisitions, legal activities.

Biologics: What Does the Future Hold?

January 1, 2013

Neil Lewis, chief technology officer at Malvern Instruments, talks about the challenges associated with biologics.

Navigating Emerging Markets

December 1, 2012

An introduction to a new series on manufacturing within global markets.

Job Security in a Changing Biopharma Environment

December 1, 2012

Results from the 2012 employment survey.

Stability in Biopharmaceutical Storage

November 1, 2012

Patrick Jackson of Vindon Scientific offers key considerations for choosing an outsourced sample storage facility.

Recent Therapeutics IPOs Outshine Market, but Performance Mixed for Broader Life-Sciences Issues

October 1, 2012

A handful of therapeutics have performed extremely well in 2012, but as a whole, life-sciences are still down from 2010.

Compressing Drug Development Timelines with Accelerated Immunoassay

August 1, 2012

Recently developed immunoassay technology platforms reduce sample volume requirements and improve cycle times.

Streamlining Batch Record Review and Approval

August 1, 2012

A one-day sign off for batch records is considered a best practice in the industry.

A 25-Year Retrospective on Bio-Engineering

July 1, 2012

Steven S. Kuwahara, PhD, principal consultant at GXP BioTechnology LLC, gives an update on "Engineering the Cell-System Interface."

Pharmaceutical Dealmaking Broadens its Partnering Base

July 1, 2012

Collaborative R&D models coincide with new ways to fund translational research.



Click here